Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Nilsson, Jonas"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 45
Tytuł:
Delayed vascular complication after collagenase injection for Dupuytren disease.
Autorzy:
Nordenskjöld J; Department of Orthopedics, Hässleholm- Kristianstad Hospitals, Hässleholm, Sweden. .; Department of Clinical Sciences- Orthopedics, Lund University, Lund, Sweden. .
Nilsson J; Department of Radiology, Kristianstad Hospital, Kristianstad, Sweden.
Kalaf R; Department of Radiology, Kristianstad Hospital, Kristianstad, Sweden.
Atroshi I; Department of Orthopedics, Hässleholm- Kristianstad Hospitals, Hässleholm, Sweden.; Department of Clinical Sciences- Orthopedics, Lund University, Lund, Sweden.
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2023 Oct 23; Vol. 24 (1), pp. 837. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article
MeSH Terms:
Dupuytren Contracture*/diagnostic imaging
Dupuytren Contracture*/drug therapy
Dupuytren Contracture*/surgery
Humans ; Microbial Collagenase/adverse effects ; Treatment Outcome ; Collagenases/adverse effects ; Injections
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Machine learning reveals limited contribution of trans-only encoded variants to the HLA-DQ immunopeptidome.
Autorzy:
Nilsson JB; Department of Health Technology, Technical University of Denmark, DK-2800, Lyngby, Denmark.
Kaabinejadian S; Pure MHC, LLC, Oklahoma City, OK, USA.; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Yari H; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Peters B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, California, USA.
Barra C; Department of Health Technology, Technical University of Denmark, DK-2800, Lyngby, Denmark.
Gragert L; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Hildebrand W; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Nielsen M; Department of Health Technology, Technical University of Denmark, DK-2800, Lyngby, Denmark. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2023 Apr 21; Vol. 6 (1), pp. 442. Date of Electronic Publication: 2023 Apr 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
HLA-DQ Antigens*/genetics
HLA-DQ Antigens*/chemistry
Autoimmune Diseases*
Humans ; HLA Antigens ; T-Lymphocytes ; Machine Learning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies.
Autorzy:
Noborn F; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Thomsen C; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Vorontsov E; Proteomics Core Facility, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Bobbio E; Department of Cardiology, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Sihlbom C; Proteomics Core Facility, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Nilsson J; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Proteomics Core Facility, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Polte CL; Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Bollano E; Department of Cardiology, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Vukusic K; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
Sandstedt J; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
Dellgren G; Department of Cardiothoracic Surgery and Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.
Karason K; Department of Cardiology, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Oldfors A; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Larson G; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2023 Mar; Vol. 30 (1), pp. 96-108. Date of Electronic Publication: 2022 Oct 09.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Transplantation*
Amyloidosis*/metabolism
Humans ; Plaque, Amyloid/pathology ; Retrospective Studies ; Proteomics/methods ; Tissue Donors ; Amyloid/metabolism ; Mass Spectrometry ; Amyloidogenic Proteins ; Biopsy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs.
Autorzy:
Forsberg EMV; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.
Riise R; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.
Saellström S; Department of Clinical Sciences, Swedish University of Agricultural Sciences, 75007 Uppsala, Sweden.
Karlsson J; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA 6009, Australia.
Alsén S; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.
Bucher V; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.
Hemminki AE; Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.; Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, 00290 Helsinki, Finland.
Olofsson Bagge R; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.
Ny L; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.
Nilsson LM; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA 6009, Australia.
Rönnberg H; Department of Clinical Sciences, Swedish University of Agricultural Sciences, 75007 Uppsala, Sweden.
Nilsson JA; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA 6009, Australia.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Jan 20; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell carcinoma.
Autorzy:
Choong OK; Department of Laboratory Medicine, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Jakobsson R; Department of Laboratory Medicine, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery and Urology, Skaraborg Hospital, Skövde, Sweden.
Bergdahl AG; Department of Urology, Institute of Clinical Science, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Brunet S; Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Kärmander A; Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Waldenström J; Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Arvidsson Y; Department of Laboratory Medicine, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Altiparmak G; Department of Laboratory Medicine, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Nilsson JA; Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, Australia.
Karlsson J; Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, Australia.
Nyström K; Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Johansson ME; Department of Laboratory Medicine, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jan 03; Vol. 18 (1), pp. e0279578. Date of Electronic Publication: 2023 Jan 03 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Renal Cell*/therapy
Carcinoma, Renal Cell*/metabolism
COVID-19*
Kidney Neoplasms*/metabolism
Humans ; SARS-CoV-2/metabolism ; Peptidyl-Dipeptidase A/metabolism ; Virus Internalization
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Isoflurane vs. propofol for sedation in invasively ventilated patients with acute hypoxemic respiratory failure: an a priori hypothesis substudy of a randomized controlled trial.
Autorzy:
Becher T; Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. .
Meiser A; Department of Anesthesiology, University Hospital Homburg/Saar, Homburg, Germany.
Guenther U; Oldenburg Research Network Emergency- and Intensive Care Medicine (OFNI), University Clinic of Anaesthesiology, Klinikum Oldenburg, Oldenburg, Germany.
Bellgardt M; Department of Anesthesiology, Katholisches Klinikum Bochum, Bochum, Germany.
Wallenborn J; Department of Anesthesiology, HELIOS Klinikum Aue, Aue, Germany.
Kogelmann K; Klinikum Emden, Anaesthesiology, Emden, Germany.
Bracht H; Department of Emergency Medicine, University Hospital Ulm, Ulm, Germany.
Falthauser A; Central Emergency Care Unit and Admission HDU, Wels General Hospital, Wels, Austria.
Nilsson J; SDS Life Science, Danderyd, Sweden.
Sackey P; Department of Physiology and Pharmacology, Unit of Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden.
Kellner P; Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Pokaż więcej
Źródło:
Annals of intensive care [Ann Intensive Care] 2022 Dec 20; Vol. 12 (1), pp. 116. Date of Electronic Publication: 2022 Dec 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data.
Autorzy:
Tanaka E; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Department of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Inoue E; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Research Administration Center, Showa University, Tokyo, Japan.
Shoji A; Medilead Inc., Tokyo, Japan.
Nilsson J; ICON plc., Stockholm, Sweden.
Papagiannopoulos C; ICON plc., Stockholm, Sweden.
Dhanda D; Bristol-Myers Squibb, Lawrenceville, New Jersey, United States of America.
Yoshizawa Y; Bristol-Myers Squibb, Tokyo, Japan.
Abe M; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Department of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Saka K; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Department of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Sugano E; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Department of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Sugitani N; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Department of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Ochiai M; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Department of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Yamaguchi R; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Department of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Ikari K; Department of Orthopedics, Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Yamanaka H; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Rheumatology, Sanno Medical Center, Tokyo, Japan.; Department of Rheumatology, International University of Health and Welfare, Tokyo, Japan.
Harigai M; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Department of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Nov 16; Vol. 17 (11), pp. e0277566. Date of Electronic Publication: 2022 Nov 16 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents*/adverse effects
Arthritis, Rheumatoid*
Aged ; Humans ; Abatacept/therapeutic use ; Japan ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells.
Autorzy:
Liang F; Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
Nilsson LM; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, UWA Centre for Medical Research, University of Western Australia, Nedlands, WA 6009, Australia.
Byvald F; Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
Rezapour A; Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
Taflin H; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, University of Gothenburg, 41345 Gothenburg, Sweden.
Nilsson JA; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, UWA Centre for Medical Research, University of Western Australia, Nedlands, WA 6009, Australia.
Yrlid U; Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Jun 10; Vol. 14 (12). Date of Electronic Publication: 2022 Jun 10.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Glycoproteomic and Phenotypic Elucidation of B4GALNT2 Expression Variants in the SID Histo-Blood Group System.
Autorzy:
Stenfelt L; Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, SE 221 85 Lund, Sweden.
Nilsson J; Proteomics Core Facility, Sahlgrenska Academy at the University of Gothenburg, SE 405 30 Gothenburg, Sweden.
Hellberg Å; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, SE 221 85 Lund, Sweden.
Liew YW; Red Cell Reference Laboratory, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Brisbane, QLD 4059, Australia.
Morrison J; Red Cell Reference Laboratory, Clinical Services and Research, Australian Red Cross Lifeblood, Kelvin Grove, Brisbane, QLD 4059, Australia.
Larson G; Laboratory of Clinical Chemistry, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, SE 413 45 Gothenburg, Sweden.
Olsson ML; Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, SE 221 85 Lund, Sweden.; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, SE 221 85 Lund, Sweden.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Apr 01; Vol. 23 (7). Date of Electronic Publication: 2022 Apr 01.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Group Antigens*/genetics
N-Acetylgalactosaminyltransferases*/genetics
N-Acetylgalactosaminyltransferases*/metabolism
HEK293 Cells ; Humans ; Phenotype
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Microenvironment of Small Intestinal Neuroendocrine Tumours Contains Lymphocytes Capable of Recognition and Activation after Expansion.
Autorzy:
Hofving T; Sahlgrenska Center for Cancer Research, Department of Pathology and Genetics, Institute of Biomedicine, University of Gothenburg, 40530 Gothenburg, Sweden.
Liang F; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, 40530 Gothenburg, Sweden.
Karlsson J; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, University of Gothenburg, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, UWA Centre for Medical Research, University of Western Australia, 6 Verdun Street, Nedlands, WA 6009, Australia.
Yrlid U; Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, 40530 Gothenburg, Sweden.
Nilsson JA; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, University of Gothenburg, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, UWA Centre for Medical Research, University of Western Australia, 6 Verdun Street, Nedlands, WA 6009, Australia.
Nilsson O; Sahlgrenska Center for Cancer Research, Department of Pathology and Genetics, Institute of Biomedicine, University of Gothenburg, 40530 Gothenburg, Sweden.
Nilsson LM; Sahlgrenska Translational Melanoma Group, Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, University of Gothenburg, 40530 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, UWA Centre for Medical Research, University of Western Australia, 6 Verdun Street, Nedlands, WA 6009, Australia.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Aug 26; Vol. 13 (17). Date of Electronic Publication: 2021 Aug 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer.
Autorzy:
Åberg AM; Department of Medical Biosciences, Pathology, Umeå University, 901 85 Umeå, Sweden.
Bergström SH; Department of Medical Biosciences, Pathology, Umeå University, 901 85 Umeå, Sweden.
Thysell E; Department of Medical Biosciences, Pathology, Umeå University, 901 85 Umeå, Sweden.
Tjon-Kon-Fat LA; Department of Radiation Sciences, Oncology, Umeå University, 901 85 Umeå, Sweden.
Nilsson JA; Department of Radiation Sciences, Oncology, Umeå University, 901 85 Umeå, Sweden.
Widmark A; Department of Radiation Sciences, Oncology, Umeå University, 901 85 Umeå, Sweden.
Thellenberg-Karlsson C; Department of Radiation Sciences, Oncology, Umeå University, 901 85 Umeå, Sweden.
Bergh A; Department of Medical Biosciences, Pathology, Umeå University, 901 85 Umeå, Sweden.
Wikström P; Department of Medical Biosciences, Pathology, Umeå University, 901 85 Umeå, Sweden.
Lundholm M; Department of Medical Biosciences, Pathology, Umeå University, 901 85 Umeå, Sweden.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 May 17; Vol. 13 (10). Date of Electronic Publication: 2021 May 17.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Socioeconomy as a prognostic factor for location of death in Swedish palliative cancer patients.
Autorzy:
Nilsson J; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden. .; Department of Radiation Sciences Umeå University Hospital, Umeå, Sweden. .; Department of Radiology, Gävle Hospital, Gävle, Sweden. .
Holgersson G; Department of Immunology Genetics and Pathology, Section of clinical and experimental oncology, Uppsala University Hospital, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden.
Ullenhag G; Department of Immunology Genetics and Pathology, Section of clinical and experimental oncology, Uppsala University Hospital, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden.
Holmgren M; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.; Department of Oncology, Gävle Hospital, Gävle, Sweden.
Axelsson B; Department of Radiation Sciences Umeå University Hospital, Umeå, Sweden.; Unit of Clinical research center, Östersund, Sweden.
Carlsson T; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.
Bergqvist M; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.; Department of Radiation Sciences Umeå University Hospital, Umeå, Sweden.; Department of Oncology, Gävle Hospital, Gävle, Sweden.
Bergström S; Center for Research & Development, Uppsala University/ County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.; Department of Radiation Sciences Umeå University Hospital, Umeå, Sweden.; Department of Oncology, Gävle Hospital, Gävle, Sweden.
Pokaż więcej
Źródło:
BMC palliative care [BMC Palliat Care] 2021 Mar 14; Vol. 20 (1), pp. 43. Date of Electronic Publication: 2021 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Home Care Services*
Neoplasms*/therapy
Terminal Care*
Humans ; Male ; Palliative Care ; Prognosis ; Sweden
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reply to Comment on Katsarelias, D., et al. "The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register Study." Cancers 2020, 12 , 3228.
Autorzy:
Katsarelias D; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.; Department of Surgery, Sahlgrenska University Hospital, 413 45 Gothenburg, Region Västra Götaland, Sweden.
Eriksson H; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.; Theme Cancer/Department of Oncology, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Mikiver R; Regional Cancer Center South East Sweden and Department of Clinical and Experimental Medicine, Linköping University, 581 83 Linköping, Sweden.
Krakowski I; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.; Theme Inflammation/Department of Dermatology, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Nilsson JA; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.; Harry Perkins Institute of Medical Research, 6009 Nedlands, Australia.
Ny L; Department of Oncology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, 405 30 Gothenburg, Sweden.
Olofsson Bagge R; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.; Department of Surgery, Sahlgrenska University Hospital, 413 45 Gothenburg, Region Västra Götaland, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, 405 30 Gothenburg, Sweden.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Dec 30; Vol. 13 (1). Date of Electronic Publication: 2020 Dec 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register Study.
Autorzy:
Katsarelias D; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.; Department of Surgery, Sahlgrenska University Hospital, 413 45 Gothenburg, Region Västra Götaland, Sweden.
Eriksson H; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.; Theme Cancer/Department of Oncology, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Mikiver R; Regional Cancer Center South East Sweden and Department of Clinical and Experimental Medicine, Linköping University, 581 83 Linköping, Sweden.
Krakowski I; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.; Theme Inflammation/Department of Dermatology, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Nilsson JA; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.
Ny L; Department of Oncology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, 405 30 Gothenburg, Sweden.
Olofsson Bagge R; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.; Department of Surgery, Sahlgrenska University Hospital, 413 45 Gothenburg, Region Västra Götaland, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, 405 30 Gothenburg, Sweden.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Nov 02; Vol. 12 (11). Date of Electronic Publication: 2020 Nov 02.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?
Autorzy:
Justo N; Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Solna, Sweden.
Nilsson J; ICON Plc, ICO, Stockholm, Sweden.
Korytowsky B; United States Health Economics Outcomes Research, Bristol-Myers Squibb, Lawrenceville, NJ, United States of America.
Dalen J; ICON Plc, ICO, Stockholm, Sweden.
Madison T; ICON Plc, ICO, Lexington, KY, United States of America.
McGuire A; Department of Health Policy, London School of Economics, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 May 12; Vol. 15 (5), pp. e0232669. Date of Electronic Publication: 2020 May 12 (Print Publication: 2020).
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*therapy
Lung Neoplasms/*therapy
Aged ; Carcinoma, Non-Small-Cell Lung/epidemiology ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/epidemiology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Proportional Hazards Models ; Retrospective Studies ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Deficiency syndromes in top predators associated with large-scale changes in the Baltic Sea ecosystem.
Autorzy:
Majaneva S; Department of Biology and Environmental Sciences, Centre for Ecology and Evolution in Microbial model Systems-EEMiS, Linnaeus University, Kalmar, Sweden.; Department of Arctic and Marine Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway.
Fridolfsson E; Department of Biology and Environmental Sciences, Centre for Ecology and Evolution in Microbial model Systems-EEMiS, Linnaeus University, Kalmar, Sweden.
Casini M; Swedish University of Agricultural Sciences, Department of Aquatic Resources, Institute of Marine Research, Lysekil, Sweden.
Legrand C; Department of Biology and Environmental Sciences, Centre for Ecology and Evolution in Microbial model Systems-EEMiS, Linnaeus University, Kalmar, Sweden.
Lindehoff E; Department of Biology and Environmental Sciences, Centre for Ecology and Evolution in Microbial model Systems-EEMiS, Linnaeus University, Kalmar, Sweden.
Margonski P; National Marine Fisheries Research Institute, Gdynia, Poland.
Majaneva M; Department of Biology and Environmental Sciences, Centre for Ecology and Evolution in Microbial model Systems-EEMiS, Linnaeus University, Kalmar, Sweden.; NTNU University Museum, Norwegian University of Science and Technology, Trondheim, Norway.
Nilsson J; Department of Biology and Environmental Sciences, Centre for Ecology and Evolution in Microbial model Systems-EEMiS, Linnaeus University, Kalmar, Sweden.
Rubene G; Fish Resources Research Department, Institute of Food Safety, Animal Health and Environment BIOR, Riga, Latvia.
Wasmund N; Leibniz-Institute for Baltic Sea Research, Warnemünde, Germany.
Hylander S; Department of Biology and Environmental Sciences, Centre for Ecology and Evolution in Microbial model Systems-EEMiS, Linnaeus University, Kalmar, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Jan 09; Vol. 15 (1), pp. e0227714. Date of Electronic Publication: 2020 Jan 09 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Animal Nutritional Physiological Phenomena*
Food Chain*
Ecological Parameter Monitoring/*statistics & numerical data
Salmo salar/*physiology
Thiamine Deficiency/*veterinary
Animals ; Ecological Parameter Monitoring/trends ; Female ; Incidence ; Oceans and Seas ; Phytoplankton/chemistry ; Thiamine/metabolism ; Thiamine Deficiency/epidemiology ; Thiamine Deficiency/etiology ; Zooplankton/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Endosomal signalling via exosome surface TGFβ-1.
Autorzy:
Shelke GV; Krefting Research Centre, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Institute of Clinical Sciences, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Yin Y; Krefting Research Centre, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Jang SC; Krefting Research Centre, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Lässer C; Krefting Research Centre, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Wennmalm S; Royal Institute of Technology-KTH, Department of Applied Physics, Experimental Biomolecular Physics Group, SciLife Laboratory, Solna, Sweden.
Hoffmann HJ; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of respiratory and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Li L; Department of Laboratory Medicine, Shanghai First People's Hospital, Shanghai JiaoTong University, Shanghai, China.
Gho YS; Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.
Nilsson JA; Department of Surgery, Institute of Clinical Sciences, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Lötvall J; Krefting Research Centre, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Journal of extracellular vesicles [J Extracell Vesicles] 2019 Sep 20; Vol. 8 (1), pp. 1650458. Date of Electronic Publication: 2019 Sep 20 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.
Autorzy:
Jespersen H; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Blå stråket 2, 413 45, Gothenburg, Sweden.
Olofsson Bagge R; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Blå stråket 5, 413 45, Gothenburg, Sweden.
Ullenhag G; Department of Radiology, Oncology and Radiation Science, Section of Oncology, Uppsala University, 751 05, Uppsala, Sweden.
Carneiro A; Department of Oncology, Skåne University Hospital, Getingevägen 4, 221 85, Lund, Sweden.
Helgadottir H; Department of Oncology, Karolinska University Hospital, Karolinska vägen, 171 76, Stockholm, Sweden.
Ljuslinder I; Department of Oncology, Norrlands University Hospital, 901 85, Umeå, Sweden.
Levin M; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Blå stråket 2, 413 45, Gothenburg, Sweden.
All-Eriksson C; St. Erik Eye Hospital, Polhemsgatan 50, 112 30, Stockholm, Sweden.
Andersson B; Department of Clinical immunology and transfusion medicine, Sahlgrenska University Hospital, Guldhedsgatan 10, 413 45, Gothenburg, Sweden.
Stierner U; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Blå stråket 2, 413 45, Gothenburg, Sweden.
Nilsson LM; Sahlgrenska Cancer Center, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Medicinaregatan 1F, 405 30, Gothenburg, Sweden.
Nilsson JA; Sahlgrenska Cancer Center, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Medicinaregatan 1F, 405 30, Gothenburg, Sweden.
Ny L; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Blå stråket 2, 413 45, Gothenburg, Sweden. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 May 02; Vol. 19 (1), pp. 415. Date of Electronic Publication: 2019 May 02.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study
MeSH Terms:
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Benzamides/*administration & dosage
Melanoma/*drug therapy
Pyridines/*administration & dosage
Uveal Neoplasms/*drug therapy
Administration, Intravenous ; Administration, Oral ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Benzamides/therapeutic use ; Drug Administration Schedule ; Female ; Humans ; Male ; Prospective Studies ; Pyridines/therapeutic use ; Research Design ; Treatment Outcome
SCR Disease Name:
Uveal melanoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Synthetic standard aided quantification and structural characterization of amyloid-beta glycopeptides enriched from cerebrospinal fluid of Alzheimer's disease patients.
Autorzy:
Nilsson J; Laboratory of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Brinkmalm G; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ramadan S; Departments of Chemistry and Biomedical Engineering, Institute for Quantitative Health, Science and Engineering, Michigan State University, East Lansing, MI, USA.; Chemistry Department, Faculty of Science, Benha University, Benha, Qaliobiya, 13518, Egypt.
Gilborne L; Laboratory of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
Noborn F; Laboratory of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Wallin A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Svensson J; Department of Internal Medicine, Institute of Medicine Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Abo-Riya MA; Chemistry Department, Faculty of Science, Benha University, Benha, Qaliobiya, 13518, Egypt.
Huang X; Departments of Chemistry and Biomedical Engineering, Institute for Quantitative Health, Science and Engineering, Michigan State University, East Lansing, MI, USA. .
Larson G; Laboratory of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden. .; Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Apr 02; Vol. 9 (1), pp. 5522. Date of Electronic Publication: 2019 Apr 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*cerebrospinal fluid
Amyloid beta-Peptides/*chemistry
Glycopeptides/*cerebrospinal fluid
Aged ; Amyloid beta-Peptides/cerebrospinal fluid ; Case-Control Studies ; Chromatography, Liquid ; Female ; Glycopeptides/chemistry ; Humans ; Male ; Middle Aged ; Molecular Structure ; Tandem Mass Spectrometry ; Tyrosine/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical, genetic and experimental studies of the Brooke-Spiegler (CYLD) skin tumor syndrome.
Autorzy:
Andersson MK; a Sahlgrenska Cancer Center, Department of Pathology , University of Gothenburg , Gothenburg , Sweden.
Kölby L; b Department of Plastic Surgery , University of Gothenburg , Gothenburg , Sweden.
Nilsson JA; c Sahlgrenska Cancer Center, Department of Surgery , University of Gothenburg , Gothenburg , Sweden.
Stenman G; a Sahlgrenska Cancer Center, Department of Pathology , University of Gothenburg , Gothenburg , Sweden.
Pokaż więcej
Źródło:
Journal of plastic surgery and hand surgery [J Plast Surg Hand Surg] 2019 Apr; Vol. 53 (2), pp. 71-75. Date of Electronic Publication: 2019 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Heterografts*/metabolism
Neoplasms, Experimental*/genetics
Neoplasms, Experimental*/metabolism
Neoplastic Syndromes, Hereditary/*genetics
Skin Neoplasms/*genetics
Aged ; Animals ; Deubiquitinating Enzyme CYLD/genetics ; Disease Models, Animal ; Germ-Line Mutation ; Humans ; Immunohistochemistry ; Male ; Mice, Knockout ; Pedigree ; Pilot Projects ; Proto-Oncogene Proteins c-myb/metabolism ; Receptor, trkC/metabolism ; Sequence Analysis, DNA
SCR Disease Name:
Familial cylindromatosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 45

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies